www.fdanews.com/articles/152975-biotech-companies-attractive-targets-for-pharmaceutical-companies-looking-to-replace-lost-revenues
Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost Revenues
February 6, 2013
Lost revenues from expiring patents have played a major part in the biotech industry's success in recent years. A total of 676 takeovers of biotechnology and pharmaceutical companies have occurred in the past three years, with an average premium of 38 percent, according to data collected by Bloomberg.
Marketwire
Marketwire